Related Experiment Video
Updated: Jun 26, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Ethical issues related to epilepsy care in the developing world
Chong-Tin Tan1, Giuliano Avanzini
1University of Malaya, Kuala Lumpur, Malaysia. editor@neurology-asia.org
Epilepsia
|January 28, 2009
Summary
Ethical dilemmas in developing nations include resource allocation for epilepsy research versus direct care. Addressing the epilepsy treatment gap and the responsibility of wealthier nations to assist poorer ones are also critical ethical considerations.
Area of Science:
- Global Health Ethics
- Neurology
- Public Health Policy
Background:
- Epilepsy care in developing countries faces significant ethical challenges.
- Limited resources exacerbate disparities in treatment access and research opportunities.
Purpose of the Study:
- To examine the ethical considerations of resource allocation for epilepsy research in developing nations.
- To analyze when the persistent epilepsy treatment gap becomes an ethical imperative.
- To explore the ethical obligations of developed countries in supporting epilepsy care globally.
Main Methods:
- Ethical analysis of resource allocation dilemmas.
- Examination of the concept of a 'treatment gap' in public health.
- Discussion of global health equity and human rights principles.
Main Results:
- Resource allocation for research must demonstrate direct community benefit.
- Ignoring the treatment gap is unethical, especially when resources are mismanaged.
- Developed nations have an ethical responsibility to aid developing countries in epilepsy care.
Conclusions:
- Balancing research investment with immediate care needs is crucial.
- Addressing the epilepsy treatment gap requires responsible resource management and international cooperation.
- Global health equity necessitates support for basic healthcare as a human right.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:27Ethical Issues
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...